Archive for February, 2008
Celgene Paints Promising Picture At Wachovia Healthcare Conference
Closed Published by Michael Bryan February 1st, 2008 in biotechAt the Wachovia Healthcare Conference, yesterday, Celgene (NASDQ: CELG)CFO, Dave Gryska, delivered good news for Celgene investors and patients. The company is generating significant cash flows (900 million) and generated $1.4 billion in total revenue. This exceeded guidance at the beginning of ‘07 projecting $1.3 billion. Additionally earnings per share (EPS) for ‘07 of $1.06 […]